Wednesday, September 9, 2026

South Sudan Oil Contamination: "Among Highest in the World," Study Finds

Terry Swartzberg

July 7, 2018

South Sudan oil workers attempting to contain the spill. Photo by: Nile Institute of Environmental Health.
MUNICH, Germany (ViaNews) - Professor Fritz Pragst of Berlin's Institute for Forensic Medicine is one of the leading forensic toxicologists in the world. Read: Briefing on Big Oil’s Contamination of South Sudan Professor Pragst headed a team of scientists that produced in 2017 the definitive study on the levels of lead, barium and other health-endangering substances in the hairs of people living in the vicinity of South Sudan's oil fields. Here is his statement on the study's findings. "The levels of lead concentrations found in the hairs of residents in South Sudan were, in some cases, among the highest in the world. While further tests - of resident blood- would be required to ascertain actual damaging of health - the direct and immediate endangerment of lead poisoning for human beings and animals is extremely well and unequivocally documented." Read: German NGO struggle for clean water in South Sudan South Sudan residents report a large number of deformed children, birth complications, and sexual dysfunctions. Read: Leading Rights Groups Reveal How a South Sudan Oil Company Plays a Key Role in Prolonging Conflict

Categories

Tags

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Investment Boom Meets Market Skepticism: Palantir's Contract Win vs. Stock Slide Amid Record Private AI Funding
Palantir secured the Army's high-profile TITAN AI-sensing contract and added a new executive, yet its stock fell 6% the same day — a sign that even marquee government AI wins no longer guarantee investor confidence. This tension plays out against a backdrop of surging private capital flooding into AI and AI-adjacent companies (Stability AI, Socure, Generalist AI, Emerald AI, and others), showing a bifurcated market: venture funding for AI remains red-hot while public-market sentiment toward AI-defense/enterprise plays is growing more cautious.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
General Motors Company
Both facts reference General Motors' cash position at the identical point in time (2025-12-31), both measuring FY 2025 period-end. Fact A reports $20.945 billion while Fact B reports $21.7 billion—a $755 million discrepancy (3.6% difference). Since they share the same entity, attribute, date, and fiscal period with conflicting values, this is a genuine contradiction, not a change over time. The difference is material enough to suggest either: different source data, different cash classifications (e.g., one includes equivalents/restricted cash), preliminary vs. final figures, or a data quality issue.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,278 source documents archived
Query this data → isubstrate.com